|
LY 294002
PI3 kinase inhibitor
Potent, cell permeable, inhibitor of PI(3)K (phosphoinositide 3-kinase) that acts on the ATP-binding site of the enzyme. Displays an IC50 of 1.4µM and inhibits all isoforms equally in in vitro assays using purified PI 3-kinase (p110α IC50=0.63µM). Inhibits Pim-1 kinase with IC50=4.0µM. Other kinases such as PKC, PKA, MAP kinase, S6 kinase, EGF receptor tyrosine kinase, c-src kinase, PI 4-kinase, diacylglycerol kinase or rabbit kidney ATPase are not inhibited at 50µM.
Induces apoptosis in many cell types by blocking the PI3-K/Akt anti-apoptotic pathway. Useful tool for identifying cellular events which are regulated by the PI3-K/Akt axis. Sensitizes tumor cells to drug-induced apoptosis independent of its PI3K inhibitory activity. Inhibits proliferation and induces apoptosis in human colon cancer cells. Suppresses proliferation of mouse embryonic stem cells. Furthermore, inhibits autophagic sequestration in rat hepatocytes.
Product Specification
Alternative Name: 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Formula: C19H17NO3
MW: 307.4
CAS: 154447-36-6
Purity: ≥98% (HPLC)
Appearance: White to pale yellow solid.
Solubility: Soluble in DMSO (25mg/ml, warm), 100% ethanol (25mg/ml, warm) or methanol.
Long Term Storage: -20°C
Use/Stability: Stable for at least 1 year after receipt when stored at -20°C. Stock solutions are stable for up to 3 months at -20°C. |